Geron Corporation To Present At UBS Warburg Global Life Sciences Conference
Menlo Park, CA – September 18, 2003 –– Geron Corporation (Nasdaq: GERN) will be presenting an update of the company’s product development programs on Monday, September 22, 2003, at the UBS Warburg Global Life Sciences Conference at 4:30 p.m., Eastern Time in New York City.
The presentation will review Geron’s portfolio of telomerase–based anti–cancer therapies, including an update of the company’s telomerase inhibitor drugs (GRN163 and GRN719), progress on its therapeutic vaccine trial at Duke, and a review of Geron’s oncolytic virus program. The presentation will also review Geron’s continued progress in developing cell therapies based on human embryonic stem cells (hESCs), including updates on the multiple cell types the company has differentiated from hESCs for the potential treatment of heart failure, spinal cord injury, Parkinson’s disease, diabetes, arthritis and osteoporosis. Thomas B. Okarma, Ph.D., M.D., Geron’s president and chief executive officer, will be giving the presentation.
The audio webcast will be available at the following website address: http://www.ibb.ubs.com. To access the webcast, click on the Conferences button and then click on the webcast link for the Global Life Sciences Conference. It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. The webcast will be archived for 30 days.
For further information, please contact Geron Corporation at 650–473–7765 or visit Geron’s website at www.geron.com.
Geron is a biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic products for applications in oncology and regenerative medicine, and research tools for drug discovery. Geron’s product development programs are based upon three patented core technologies: telomerase, human embryonic stem cells and nuclear transfer.
Contact: Geron Corporation Investor and Public Relations Tel: 650–473–7765
Additional information about the company can be obtained at http://www.geron.com.
